Large cell neuroendocrine carcinoma
Clinical trials for Large cell neuroendocrine carcinoma explained in plain language.
Never miss a new study
Get alerted when new Large cell neuroendocrine carcinoma trials appear
Sign up with your email to follow new studies for Large cell neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare tumors: tarlatamab trial opens
Disease control OngoingThis study tests the drug tarlatamab in people with advanced tumors that have a protein called DLL3. The goal is to see if the drug can shrink or control these tumors. About 29 adults with stage IV cancer will receive tarlatamab, and researchers will track how well it works and a…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug combo tested for tough cancers
Disease control OngoingThis early-phase trial tests an investigational drug called ABBV-706, alone or combined with other drugs, in about 288 adults with advanced solid tumors like small cell lung cancer, high-grade brain tumors, and neuroendocrine cancers. The main goals are to check safety, find the …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC